Health
Access to cancer medicines and clinical trials show stark variations across Europe – Medical Xpress
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to resul…
Access to cancer medicines is highly unequal across Europe both for new drugs in development because of uneven access to clinical trials and for currently approved drugs due to huge disparities in healthcare spending by different countries, according to results from studies presented at ESMO 2020.
Countries in Western Europe run a higher number of clinical trials for novel cancer treatments than countries in Eastern and Central Europe, showed an analysis of clinical trials active in different c…
-
General11 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General14 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News23 hours agoBrisbane State High School wants playing fields, not apartment towers at Visy riverside site
-
General13 hours agoGold Coast and Noosa councils scammed out of ratepayers’ money
